Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer
Nicholas Spetsieris, Myrto Boukovala, Ioannis Alafis, John W. Davis, Amado J. Zurita, Xuemei Wang, Shi‐Ming Tu, Brian F. Chapin, Ana M. Aparicio, Paul G. Corn, Jennifer Wang, Sumit K. Subudhi, John C. Araujo, John Papadopoulos, Lisa Pruitt, Justin A. Weldon, Christopher J. Logothetis, Eleni Efstathiou
Topics & Concepts
MedicineAndrogen deprivation therapyProstate cancerAbiraterone acetateHazard ratioPrednisoneUrologyClinical endpointProstatectomySurgeryRandomized controlled trialConfidence intervalInternal medicineCancerProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications